MOMENTA PHARMACEUTICALS INC's ticker is MNTA and the CUSIP is 60877T100. A total of 162 filers reported holding MOMENTA PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 0.41 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $260,616,000 | +1060.3% | 4,966,005 | +635.6% | 0.32% | +935.5% |
| Q2 2020 | $22,462,000 | +9.4% | 675,131 | -10.6% | 0.03% | -32.6% |
| Q1 2020 | $20,538,000 | +270.0% | 755,070 | +76.3% | 0.05% | +411.1% |
| Q3 2019 | $5,551,000 | +16.8% | 428,336 | +12.3% | 0.01% | +28.6% |
| Q2 2019 | $4,751,000 | +102.3% | 381,567 | +136.1% | 0.01% | +75.0% |
| Q1 2019 | $2,348,000 | -17.7% | 161,628 | -37.5% | 0.00% | 0.0% |
| Q4 2018 | $2,854,000 | -60.5% | 258,472 | -5.9% | 0.00% | -55.6% |
| Q3 2018 | $7,226,000 | -40.5% | 274,749 | -58.9% | 0.01% | -43.8% |
| Q1 2018 | $12,145,000 | -5.3% | 669,149 | -27.2% | 0.02% | -11.1% |
| Q4 2017 | $12,830,000 | +682.3% | 919,692 | +648.6% | 0.02% | +500.0% |
| Q1 2017 | $1,640,000 | -91.2% | 122,858 | -90.1% | 0.00% | -92.3% |
| Q4 2016 | $18,731,000 | +2.2% | 1,244,574 | -20.6% | 0.04% | +25.8% |
| Q3 2016 | $18,320,000 | +251.8% | 1,567,167 | +225.0% | 0.03% | +158.3% |
| Q2 2016 | $5,207,000 | +2.0% | 482,143 | -12.7% | 0.01% | -7.7% |
| Q1 2016 | $5,103,000 | -63.9% | 552,314 | -42.0% | 0.01% | -56.7% |
| Q4 2015 | $14,123,000 | -26.0% | 951,675 | -18.1% | 0.03% | -18.9% |
| Q3 2015 | $19,075,000 | -7.0% | 1,162,414 | +29.3% | 0.04% | -5.1% |
| Q2 2015 | $20,509,000 | +33.2% | 899,122 | -11.2% | 0.04% | +34.5% |
| Q1 2015 | $15,396,000 | +8.9% | 1,012,875 | -13.8% | 0.03% | -3.3% |
| Q4 2014 | $14,140,000 | -4.6% | 1,174,403 | -10.1% | 0.03% | -21.1% |
| Q3 2014 | $14,819,000 | +29.0% | 1,306,834 | +37.4% | 0.04% | +22.6% |
| Q2 2014 | $11,491,000 | +11.5% | 951,268 | +7.5% | 0.03% | +3.3% |
| Q1 2014 | $10,308,000 | -10.5% | 884,848 | +35.8% | 0.03% | -16.7% |
| Q4 2013 | $11,516,000 | +63.1% | 651,355 | +32.7% | 0.04% | +56.5% |
| Q3 2013 | $7,061,000 | -28.0% | 490,708 | -24.6% | 0.02% | -23.3% |
| Q2 2013 | $9,806,000 | – | 651,135 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 450,000 | $7,605,000 | 3.18% |
| ARMISTICE CAPITAL, LLC | 820,000 | $13,858,000 | 1.77% |
| Marcus Capital, LLC | 104,000 | $1,758,000 | 1.50% |
| SECTOR GAMMA AS | 605,545 | $10,234,000 | 1.49% |
| Palo Alto Investors LP | 1,787,576 | $30,210,000 | 1.41% |
| SECTORAL ASSET MANAGEMENT INC | 299,400 | $5,060,000 | 0.55% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 433,060 | $7,318,000 | 0.53% |
| DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 1,232,929 | $20,837,000 | 0.51% |
| Orbimed Advisors | 2,109,068 | $35,643,000 | 0.37% |
| TFS CAPITAL LLC | 52,290 | $884,000 | 0.35% |